Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04632498 · ClinicalTrials.gov registry record · NA
Investigating Biological Markers, Targets, and Intervention for Mood Disorders
A NA study, sponsored by Vanderbilt University Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 61
- Enrollment target
NCT04632498: Clinical Trial NA study, sponsored by Vanderbilt University Medical Center.
NCT04632498 is a NA study that was terminated before completion, run by Vanderbilt University Medical Center. The registered enrollment target is 61 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04632498, a NA study, was terminated before completion, sponsored by Vanderbilt University Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
Study Summary
This multi-modal methods study will investigate neurophysiological, endocrinological, cognitive, psycho-social-emotional markers of disease, and targets for integrative health treatments in mood disorders.
Primary Outcome
Event-Related Potentials (ERPs)
Interventions
- BEHAVIORAL Mindfulness Based Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2021-10-26 |
| Est. Completion | 2024-04-03 |
| Phase | NA |
Why NCT04632498 stopped before completion
NCT04632498 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 61 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Mindfulness Based Intervention is the first listed.
NCT04632498 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04632498 about?
NCT04632498 is a clinical study titled "Investigating Biological Markers, Targets, and Intervention for Mood Disorders". This multi-modal methods study will investigate neurophysiological, endocrinological, cognitive, psycho-social-emotional markers of disease, and targets for integrative health treatments in mood disorders.
What is the current status of trial NCT04632498?
This trial is currently terminated. It is a NA study. The enrollment target is 61 participants. The study started on 2021-10-26. Estimated completion is 2024-04-03.
What interventions are being tested in trial NCT04632498?
The interventions under investigation include: Mindfulness Based Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04632498?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04632498's enrollment target sits among peer trials
61 1164th of 2000 higher than 837 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI